Biotherapy monitoring, a major area of interest at the European Crohn's and Colitis Organisation (ECCO) Congress
Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study
![Galapagos Reports Positive Phase 2 Trial Data of Crohn's Disease Drug Filgotinib at ECCO Congress - IBD News Today Galapagos Reports Positive Phase 2 Trial Data of Crohn's Disease Drug Filgotinib at ECCO Congress - IBD News Today](https://ibdnewstoday.com/wp-content/uploads/2016/03/shutterstock_392092564-375x480@2x.jpg)
Galapagos Reports Positive Phase 2 Trial Data of Crohn's Disease Drug Filgotinib at ECCO Congress - IBD News Today
![Gianluca Pellino on Twitter: "@EuroSurg 1 poster on at 11 ECCO Congress in Amsterdam. We are spreading! https://t.co/VnibnJrvlu" / Twitter Gianluca Pellino on Twitter: "@EuroSurg 1 poster on at 11 ECCO Congress in Amsterdam. We are spreading! https://t.co/VnibnJrvlu" / Twitter](https://pbs.twimg.com/media/CdvS3_kWoAALoxM.jpg)